Vet World Vol.10 September-2017 Article-21
Research Article
Veterinary World, 10(9): 1143-1148
https://doi.org/10.14202/vetworld.2017.1143-1148
Congenital arthrogryposis-hydranencephaly syndrome caused by Akabane virus in newborn calves of Basrah Governorate, Iraq
Background and Aim: The study was conducted in Basrah, Iraq, to diagnose congenital arthrogryposis-hydranencephaly syndrome caused by Akabane virus (AKAV) in calves.
Materials and Methods: Affected animals (42 calves) are about 2-27 days old from both sexes show signs of arthrogryposis and hydranencephaly. Eight clinically healthy newborn calves were considered as controls. Diagnosis of AKAV was confirmed using a competition enzyme-linked immunosorbent assay test.
Results: Results show that all affected calves were found seropositive. Furthermore, a significant increase in total leukocyte count in diseased calves due to a significant increase in the absolute lymphocyte number indicated in affected calves than in controls. Moreover, a significant increase in sedimentation rate of erythrocytes was also encountered in diseased calves than in controls. In addition, a significant increase in haptoglobin level and fibrinogen was also detected.
Conclusion: Diagnosis of AKAV infection of Basrah Governorate, Iraq, will provide useful epidemiological information for cattle and other domesticated animals. Therefore, abortion could be prevented and controlled. Keywords: Akabane virus, arthrogryposis-hydranencephaly, calves, Iraq.
Keywords: Akabane virus, arthrogryposis-hydranencephaly, calves, Iraq.
How to cite this article: Alsaad KM, Alautaish HHN, Alamery MAY (2017) Congenital arthrogryposis-hydranencephaly syndrome caused by Akabane virus in newborn calves of Basrah Governorate, Iraq, Veterinary World, 10(9): 1143-1148.
Received: 15-06-2017 Accepted: 30-08-2017 Published online: 29-09-2017
Corresponding author: K. M. Alsaad E-mail: kamalsad58@yahoo.com
DOI: 10.14202/vetworld.2017.1143-1148
Copyright: Alsaad, et al. This article is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.